„”
Dr
Conor completed his bachelor's and doctoral studies at University College Dublin, Ireland, and was a visiting scholar at the Johns Hopkins Bloomberg School of Public Health. In 2020, he joined the Max Planck Institute of Colloids and Interfaces as a Marie Curie fellow and, during this time, was a visiting scientist at the MPI for Marine Microbiology. In 2025, he joined the Medicinal Chemistry Research Group at the Leibniz Research Institute for Molecular Pharmacology (FMP).
Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen
ACS Infectious Diseases 2024
read onlineNovel sulfatase cancer therapeutics negatively impact Bacteroidota of the colonic microbiota in a non-sulfatase dependent manner
Semisynthetic Glycoconjugate Vaccine Candidates against Cryptococcus neoformans
ACS Infectious Diseases 2024
read onlineThe structure of a Cryptococcus neoformans polysaccharide motif recognized by protective antibodies: A combined NMR and MD study
Proceedings of the National Academy of Sciences 2024
read onlineAutomated Synthesis of Algal Fucoidan Oligosaccharides
Journal of the American Chemical Society 2024
read onlinePolyelectrolyte mannan from diatoms reshapes sunlit ocean microbiome
De novo glycan annotation of mass spectrometry data
Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture
Journal of Biological Chemistry 2022
read onlineLyophilization induces physicochemical alterations in cryptococcal exopolysaccharide
Carbohydrate Polymers 2022
read onlineGlycoside hydrolase from the GH76 family indicates that marine Salegentibacter sp. Hel_I_6 consumes alpha-mannan from fungi
The ISME Journal 2022
read onlineDefining the Qualities of High-Quality Palladium on Carbon Catalysts for Hydrogenolysis
Organic Process Research & Development 2021
read onlineOptimized Henry Reaction Conditions for the Synthesis of an l-Fucose C-Glycosyl Derivative
Carbohydrate Chemistry 2021
A glycan FRET assay for detection and characterization of catalytic antibodies to the Cryptococcus neoformans capsule
Proceedings of the National Academy of Sciences 2021
read onlineA synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes
Chemical Science 2020
read onlineOptimized Conditions for the Palladium-Catalyzed Hydrogenolysis of Benzyl and Naphthylmethyl Ethers: Preventing Saturation of Aromatic Protecting Groups
European Journal of Organic Chemistry 2020
read onlineConvergent total synthesis of Cryptococcus neoformans serotype B capsule repeating motif
Carbohydrate Research 2020
read onlineExploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe
Journal of Biological Chemistry 2020
read onlineVariation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas
mSphere 2020
read onlineThe Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10,
13125 Berlin, Germany